141 related articles for article (PubMed ID: 36437569)
1. Utility of combined gadoxetic acid and ferumoxytol-enhanced liver MRI for preoperative detection of colorectal cancer liver metastases: a pilot study.
Carney BW; Gholami S; Fananapazir G; Sekhon S; Lamba R; Loehfelm TW; Wilson MD; Corwin MT
Acta Radiol; 2023 Apr; 64(4):1357-1362. PubMed ID: 36437569
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection.
Granata V; Fusco R; de Lutio di Castelguidone E; Avallone A; Palaia R; Delrio P; Tatangelo F; Botti G; Grassi R; Izzo F; Petrillo A
BMC Gastroenterol; 2019 Jul; 19(1):129. PubMed ID: 31340755
[TBL] [Abstract][Full Text] [Related]
3. Combined gadoxetic acid and gadofosveset enhanced liver MRI for detection and characterization of liver metastases.
Bannas P; Bookwalter CA; Ziemlewicz T; Motosugi U; Munoz Del Rio A; Potretzke TA; Nagle SK; Reeder SB
Eur Radiol; 2017 Jan; 27(1):32-40. PubMed ID: 27137648
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic performance of a simulated "short" gadoxetic acid-enhanced MRI protocol is similar to that of a conventional protocol for the detection of colorectal liver metastases.
Ghorra C; Pommier R; Piveteau A; Rubbia-Brandt L; Vilgrain V; Terraz S; Ronot M
Eur Radiol; 2021 Apr; 31(4):2451-2460. PubMed ID: 33025173
[TBL] [Abstract][Full Text] [Related]
5. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK
Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324
[TBL] [Abstract][Full Text] [Related]
6. Role of gadoxetic acid-enhanced magnetic resonance imaging in the preoperative evaluation of small hepatic lesions in patients with colorectal cancer.
Cho JY; Lee YJ; Han HS; Yoon YS; Kim J; Choi Y; Shin HK; Lee W
World J Surg; 2015 May; 39(5):1161-6. PubMed ID: 25609116
[TBL] [Abstract][Full Text] [Related]
7. Lesion detection performance of an abbreviated gadoxetic acid-enhanced MRI protocol for colorectal liver metastasis surveillance.
Canellas R; Patel MJ; Agarwal S; Sahani DV
Eur Radiol; 2019 Nov; 29(11):5852-5860. PubMed ID: 30888485
[TBL] [Abstract][Full Text] [Related]
8. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent gadoxetic acid.
Lee KH; Lee JM; Park JH; Kim JH; Park HS; Yu MH; Yoon JH; Han JK; Choi BI
Korean J Radiol; 2013; 14(6):894-904. PubMed ID: 24265564
[TBL] [Abstract][Full Text] [Related]
9. Abbreviated Gadoxetic Acid-Enhanced MRI for the Detection of Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Adenocarcinoma.
Yamaguchi T; Sofue K; Ueshima E; Ueno Y; Tsujita Y; Yabe S; Shirakawa S; Toyama H; Hori M; Fukumoto T; Murakami T
J Magn Reson Imaging; 2022 Sep; 56(3):725-736. PubMed ID: 35005813
[TBL] [Abstract][Full Text] [Related]
10. Is MRI of the Liver Needed During Routine Preoperative Workup for Colorectal Cancer?
Kang SI; Kim DW; Cho JY; Park J; Lee KH; Son IT; Oh HK; Kang SB
Dis Colon Rectum; 2017 Sep; 60(9):936-944. PubMed ID: 28796732
[TBL] [Abstract][Full Text] [Related]
11. Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation.
Scharitzer M; Ba-Ssalamah A; Ringl H; Kölblinger C; Grünberger T; Weber M; Schima W
Eur Radiol; 2013 Aug; 23(8):2187-96. PubMed ID: 23519439
[TBL] [Abstract][Full Text] [Related]
12. Additional value of gadoxetic acid-enhanced MRI to conventional extracellular gadolinium-enhanced MRI for the surgical management of colorectal and neuroendocrine liver metastases.
Morin C; Drolet S; Daigle C; Deshaies I; Ouellet JF; Ball CG; Dixon E; Marceau J; Ouellet JB
HPB (Oxford); 2020 May; 22(5):710-715. PubMed ID: 31640929
[TBL] [Abstract][Full Text] [Related]
13. Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial?
Kim YK; Kim CS; Han YM; Lee YH
Clin Radiol; 2011 Jun; 66(6):489-96. PubMed ID: 21367403
[TBL] [Abstract][Full Text] [Related]
14. Non-contrast liver MRI as an alternative to gadoxetic acid-enhanced MRI for liver metastasis from colorectal cancer.
Hwang JA; Kim YK; Min JH; Song KD; Sohn I; Ahn HS
Acta Radiol; 2019 Apr; 60(4):441-450. PubMed ID: 30130970
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤ 1.5 cm in diameter).
Kim YK; Lee MW; Lee WJ; Kim SH; Rhim H; Lim JH; Choi D; Kim YS; Jang KM; Lee SJ; Lim HK
Invest Radiol; 2012 Mar; 47(3):159-66. PubMed ID: 22330426
[TBL] [Abstract][Full Text] [Related]
16. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.
Chung WS; Kim MJ; Chung YE; Kim YE; Park MS; Choi JY; Kim KW
J Magn Reson Imaging; 2011 Aug; 34(2):345-53. PubMed ID: 21702068
[TBL] [Abstract][Full Text] [Related]
17. Gadoxetic acid-enhanced MRI and diffusion-weighted imaging for the detection of colorectal liver metastases after neoadjuvant chemotherapy.
Yu MH; Lee JM; Hur BY; Kim TY; Jeong SY; Yi NJ; Suh KS; Han JK; Choi BI
Eur Radiol; 2015 Aug; 25(8):2428-36. PubMed ID: 25899413
[TBL] [Abstract][Full Text] [Related]
18. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy.
Hosseini-Nik H; Fischer SE; Moulton CA; Karbhase G; Menezes RJ; Gallinger S; Jhaveri KS
Abdom Radiol (NY); 2016 Feb; 41(2):231-8. PubMed ID: 26867904
[TBL] [Abstract][Full Text] [Related]
20. Detection of small hepatocellular carcinoma: can gadoxetic acid-enhanced magnetic resonance imaging replace combining gadopentetate dimeglumine-enhanced and superparamagnetic iron oxide-enhanced magnetic resonance imaging?
Kim YK; Kim CS; Han YM; Park G
Invest Radiol; 2010 Nov; 45(11):740-6. PubMed ID: 20644488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
